SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-315086
Filing Date
2013-08-01
Accepted
2013-08-01 16:16:24
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d546739d10q.htm 10-Q 648659
2 EX-31.1 d546739dex311.htm EX-31.1 10717
3 EX-31.2 d546739dex312.htm EX-31.2 10582
4 EX-32.1 d546739dex321.htm EX-32.1 5100
5 EX-32.2 d546739dex322.htm EX-32.2 5121
  Complete submission text file 0001193125-13-315086.txt   6404034

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20130630.xml EX-101.INS 663472
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20130630.xsd EX-101.SCH 37801
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20130630_cal.xml EX-101.CAL 53752
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20130630_def.xml EX-101.DEF 240168
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20130630_lab.xml EX-101.LAB 352071
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20130630_pre.xml EX-101.PRE 277988
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 131002933
SIC: 2834 Pharmaceutical Preparations